Table 2. Resource use, cost and outcome in the combined PATCH trials.
Antibiotic, | N = 196 | Placebo, | N = 201 | ||||
Mean | (SD) | Mean | (SD) | Δ* | (95% CI ) | p | |
GP visits | 3.41 | (17.90) | 2.84 | (11.64) | 0.57 | (−2.20 to 3.68) | 0.76 |
Community nurse visits | 6.61 | (44.32) | 2.13 | (14.10) | 4.48 | (−1.08 to 11.64) | 0.22 |
Inpatient stays | 0.16 | (0.56) | 0.15 | (0.55) | 0.00 | (−0.11 to 0.11) | 0.94 |
Inpatient days | 0.98 | (3.66) | 2.06 | (15.25) | −1.08 | (−3.59 to 0.53) | 0.46 |
Outpatient visits | 0.41 | (1.63) | 0.61 | (3.04) | −0.19 | (−0.73 to 0.23) | 0.46 |
Days off work | 3.17 | (14.98) | 5.10 | (19.61) | −1.94 | (−5.38 to 1.33) | 0.27 |
Drugs cost+ | |||||||
Study, rc = 0% | 29.82 | − | 0.00 | − | 29.82 | (28.63 to 30.95) | <0.001 |
Non-study, rc = 0% | 16.22 | (65.32) | 18.23 | (55.86) | −2.01 | (−14.49 to 9.80) | 0.76 |
NHS treatment cost+ | |||||||
rc = 0% | 722 | (2090) | 927 | (4931) | −205 | (−1049 to 402) | 0.63 |
rc = 3.5% | 704 | (2034) | 900 | (4768) | −197 | (−1009 to 387) | 0.63 |
rc = 5% | 696 | (2011) | 889 | (4702) | −193 | (−992 to 384) | 0.63 |
Societal Cost+ | |||||||
rc = 0% | 1069 | (2750) | 1486 | (6437) | −417 | (−1479 to 383) | 0.48 |
rc = 3.5% | 1047 | (2698) | 1452 | (6240) | −406 | (−1440 to 375) | 0.48 |
rc = 5% | 1038 | (2678) | 1439 | (6159) | −401 | (−1426 to 371) | 0.48 |
Recurrence rate | |||||||
rc = 0% | 0.755 | (1.278) | 1.060 | (1.434) | −.305 | (−0.588 to −0.050) | 0.02 |
rc = 3.5% | 0.732 | (1.233) | 1.034 | (1.394) | −.303 | (−0.575 to −0.054) | 0.02 |
rc = 5% | 0.722 | (1.215) | 1.024 | (1.378) | −.302 | (−0.572 to −0.056) | 0.02 |
*Δ: Antibiotic – Placebo.
2010 costs; rc refers to the discount rates applied to costs distributed over time.